the role of angiotensin ii ( ang ii ) in the drinking and secretion of avp in response to decreased venous return was evaluated using the ang ii receptor blocker , saralasin , infused intravenously ( iv ) or intracerebroventricularly ( icv ) .
C0003009
angiotensin ii
C0036193
saralasin